Method of wound healing using A2B adenosine receptor antagonists

Details for Australian Patent Application No. 2005282860 (hide)

Owner Gilead Palo Alto, Inc.

Inventors Zeng, Dewan; Belardinelli, Luiz

Agent Freehills

Pub. Number AU-B-2005282860

PCT Pub. Number WO2006/028810

Priority 60/606,675 01.09.04 US

Filing date 30 August 2005

Wipo publication date 16 March 2006

Acceptance publication date 22 March 2012

International Classifications

A61K 31/522 (2006.01)

A61P 17/02 (2006.01) Drugs for dermatological disorders

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/028810 Priority application(s): WO2006/028810

15 October 2009 Alteration of Name

  The name of the applicant has been altered to Gilead Palo Alto, Inc. 2007

22 March 2012 Application Accepted

  Published as AU-B-2005282860

29 March 2012 Assignment before Grant

  Gilead Palo Alto, Inc. The application has been assigned to Gilead Sciences, Inc.

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282871-Delivery system which facilitates hydration of an intraluminal medical device

2005282857-Dust mop having dust-collecting protrusions